MERTK and metabolic dysfunction-associated steatohepatitis: Specifically, MerTK signaling in macrophages activates the ERK1/2 pathway leading to increased TGFβ expression, and myeloid cell-specific targeting of MerTK in mice fed a NASH-inducing diet partially protects from liver fibrosis development [120].